Campodonico W, Mohan H, Huynh P, Black H, Lau C, Paulson H
PLoS One. 2025; 19(12):e0310946.
PMID: 39775359
PMC: 11684626.
DOI: 10.1371/journal.pone.0310946.
Hossain M, Nyame P, Monde K
Biomolecules. 2024; 14(3).
PMID: 38540701
PMC: 10968565.
DOI: 10.3390/biom14030280.
Zhang R, Mele V, Robben L, Kane M
J Virol. 2023; 97(5):e0193022.
PMID: 37093008
PMC: 10231236.
DOI: 10.1128/jvi.01930-22.
Middlebrook E, Stark D, Cornwall D, Kubinak J, Potts W
Front Genet. 2021; 12:716623.
PMID: 34512727
PMC: 8430262.
DOI: 10.3389/fgene.2021.716623.
Salas-Briceno K, Zhao W, Ross S
Viruses. 2020; 12(11).
PMID: 33121095
PMC: 7692085.
DOI: 10.3390/v12111217.
Distribution of endogenous gammaretroviruses and variants of the Fv1 restriction gene in individual mouse strains and strain subgroups.
Skorski M, Bamunusinghe D, Liu Q, Shaffer E, Kozak C
PLoS One. 2019; 14(7):e0219576.
PMID: 31291374
PMC: 6619830.
DOI: 10.1371/journal.pone.0219576.
A Naturally Occurring Domestic Cat APOBEC3 Variant Confers Resistance to Feline Immunodeficiency Virus Infection.
Yoshikawa R, Izumi T, Yamada E, Nakano Y, Misawa N, Ren F
J Virol. 2015; 90(1):474-85.
PMID: 26491161
PMC: 4702554.
DOI: 10.1128/JVI.02612-15.
Infectivity and insertional mutagenesis of endogenous retrovirus in autoimmune NZB and B/W mice.
Beck-Engeser G, Ahrends T, Knittel G, Wabl R, Metzner M, Eilat D
J Gen Virol. 2015; 96(11):3396-3410.
PMID: 26315139
PMC: 4806582.
DOI: 10.1099/jgv.0.000271.
Use of IRF-3 and/or IRF-7 knockout mice to study viral pathogenesis: lessons from a murine retrovirus-induced AIDS model.
OConnor M, Green W
J Virol. 2013; 88(4):2349-53.
PMID: 24335302
PMC: 3911529.
DOI: 10.1128/JVI.02960-13.
Ordered assembly of murine leukemia virus capsid protein on lipid nanotubes directs specific binding by the restriction factor, Fv1.
Hilditch L, Matadeen R, Goldstone D, Rosenthal P, Taylor I, Stoye J
Proc Natl Acad Sci U S A. 2011; 108(14):5771-6.
PMID: 21436027
PMC: 3078404.
DOI: 10.1073/pnas.1100118108.
Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors.
Groom H, Yap M, Galao R, Neil S, Bishop K
Proc Natl Acad Sci U S A. 2010; 107(11):5166-71.
PMID: 20194752
PMC: 2841911.
DOI: 10.1073/pnas.0913650107.
Are viruses inhibited by APOBEC3 molecules from their host species?.
Ross S
PLoS Pathog. 2009; 5(4):e1000347.
PMID: 19390611
PMC: 2667636.
DOI: 10.1371/journal.ppat.1000347.
Expression of murine APOBEC3 alleles in different mouse strains and their effect on mouse mammary tumor virus infection.
Okeoma C, Petersen J, Ross S
J Virol. 2009; 83(7):3029-38.
PMID: 19153233
PMC: 2655539.
DOI: 10.1128/JVI.02536-08.
Antiviral strategies.
Muller B, Krausslich H
Handb Exp Pharmacol. 2008; (189):1-24.
PMID: 19048195
PMC: 7120301.
DOI: 10.1007/978-3-540-79086-0_1.
Friend virus utilizes the BMP4-dependent stress erythropoiesis pathway to induce erythroleukemia.
Subramanian A, Hegde S, Porayette P, Yon M, Hankey P, Paulson R
J Virol. 2007; 82(1):382-93.
PMID: 17942544
PMC: 2224407.
DOI: 10.1128/JVI.02487-06.
Fusion of cyclophilin A to Fv1 enables cyclosporine-sensitive restriction of human and feline immunodeficiency viruses.
Schaller T, Ylinen L, Webb B, Singh S, Towers G
J Virol. 2007; 81(18):10055-63.
PMID: 17609268
PMC: 2045386.
DOI: 10.1128/JVI.00616-07.
Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection.
Luban J
J Virol. 2006; 81(3):1054-61.
PMID: 16956947
PMC: 1797489.
DOI: 10.1128/JVI.01519-06.
All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction.
Ohkura S, Yap M, Sheldon T, Stoye J
J Virol. 2006; 80(17):8554-65.
PMID: 16912305
PMC: 1563890.
DOI: 10.1128/JVI.00688-06.
Retroviral restriction factors Fv1 and TRIM5alpha act independently and can compete for incoming virus before reverse transcription.
Passerini L, Keckesova Z, Towers G
J Virol. 2006; 80(5):2100-5.
PMID: 16474118
PMC: 1395401.
DOI: 10.1128/JVI.80.5.2100-2105.2006.
Resistance to friend virus-induced erythroleukemia in W/W(v) mice is caused by a spleen-specific defect which results in a severe reduction in target cells and a lack of Sf-Stk expression.
Subramanian A, Teal H, Correll P, Paulson R
J Virol. 2005; 79(23):14586-94.
PMID: 16282458
PMC: 1287579.
DOI: 10.1128/JVI.79.23.14586-14594.2005.
